Furong Zeng

Central South University — China

Medicine · Health Sciences

30h-index3.6kcitations105works31.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(25), Ferroptosis and cancer prognosis(15), SARS-CoV-2 and COVID-19 Research(11), Cancer Immunotherapy and Biomarkers(11), Cancer, Lipids, and Metabolism(11)

Publications105 total

Predictive nursing to reduce PICC-related thrombosis and psychological distress in cancer patients
Psycho-Oncologie·2025Open Access
Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy
Biomedicines·2025Open Access
Sleep patterns and the risk of psoriatic disease: genetic predisposition and metabonomics
British Journal of Dermatology·2025· 1 cited
Nonkeratinocyte skin cancer in survivors of childhood, adolescent, and young adult cancer with and without radiotherapy
JAAD International·2025Open Access
Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis
Cell Reports Medicine·2025· 3 citedOpen Access
Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment
Molecular Cancer·2025· 22 citedOpen Access
Disparities in survival and tumor characteristics in patients with single and multiple primary Merkel cell carcinomas
Journal of the American Academy of Dermatology·2025
The Metabolomic Profile of a Healthy Lifestyle Mediates Psoriasis Risk and Predicts Multiple Comorbidities
2025Open Access
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Redox Biology·2025· 25 citedOpen Access
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer
Signal Transduction and Targeted Therapy·2025· 61 citedOpen Access
Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy
Discover Oncology·2025· 5 citedOpen Access
Differential impact of immune-mediated inflammatory diseases before versus after cancer on patient survival: a nationwide cohort study
Lara D. Veeken·2025· 1 cited
Protection of Novel Adenovirus Vectored Vaccine in Rats Against Wild‐Type Hepacivirus and Variant Infections
Liver International·2025· 2 citedOpen Access
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
Human Vaccines & Immunotherapeutics·2025· 12 citedOpen Access
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity
Journal of Translational Internal Medicine·2025· 45 citedOpen Access
Ferroptosis: A Targetable Vulnerability for Melanoma Treatment
Journal of Investigative Dermatology·2025· 11 cited
Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases
Diabetes & Metabolic Syndrome Clinical Research & Reviews·2025· 10 cited
D-dimer for efficacy prediction in COVID-19 patients treated with paxlovid
BMC Infectious Diseases·2024Open Access
Ferroptosis: mechanisms and therapeutic targets
MedComm·2024· 38 citedOpen Access
Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma
Journal for ImmunoTherapy of Cancer·2024· 10 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Guangtong Deng(46), Xiang Chen(12), Mingzhu Yin(11), Xiang Chen(11), Yating Dian(11), Huiyan Sun(10), Yuming Sun(7), Lei Yao(6), Jiayuan Le(6), Songtao Du(6), Yuming Sun(5), Minxue Shen(5), Yu Meng(5), Yu Meng(4), Daishi Li(4), Juan Su(4), Shuang Zhao(4), Mengting Liao(4), Ziyu Guo(4), Yayun Li(4)